24
Views
3
CrossRef citations to date
0
Altmetric
Original

Inflammatory Responses Underlying the Microvascular Dysfunction Associated with Obesity and Insulin Resistance

&
Pages 375-387 | Received 11 Dec 2006, Accepted 16 Jan 2007, Published online: 10 Jul 2009

REFERENCES

  • Aggarwal B B, Natarajan K. Tumor necrosis factors: developments during the last decade. Eur Cytokine Netw 1996; 7: 93–124
  • Ahima R S, Flier J S. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000; 11: 327–332
  • Aljada A, Ghanim H, Mohanty P, Kapur N, Dandona P. Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations. J Clin Endocrinol Metab 2002; 87: 1419–1422
  • Alvarez A, Sanz M J. Reactive oxygen species mediate angiotensin II-induced leukocyte-endothelial cell interactions in vivo. J Leukoc.Biol 2001; 70: 199–206
  • Arcaro G, Zamboni M, Rossi L, Turcato E, Covi G, Armellini F, Bosello O, Lechi A. Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. Int J Obes Relat Metab Disord 1999; 23: 936–942
  • Arvidsson E, Viguerie N, Andersson I, Verdich C, Langin D, Arner P. Effects of different hypocaloric diets on protein secretion from adipose tissue of obese women. Diabetes 2004; 53: 1966–1971
  • Azuma K, Katsukawa F, Oguchi S, Murata M, Yamazaki H, Shimada A, Saruta T. Correlation between serum resistin level and adiposity in obese individuals. Obes Res 2003; 11: 997–1001
  • Banerjee R R, Rangwala S M, Shapiro J S, Rich A S, Rhoades B, Qi Y, Wang J, Rajala M W, Pocai A, Scherer P E, Steppan C M, Ahima R S, Obici S, Rossetti L, Lazar M A. Regulation of fasted blood glucose by resistin. Science 2004; 303: 1195–1198
  • Bienz M, Dai W J, Welle M, Gottstein B, Muller N. Interleukin-6-deficient mice are highly susceptible to Giardia lamblia infection but exhibit normal intestinal immunoglobulin A responses against the parasite. Infect Immun 2003; 71: 1569–1573
  • Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005; 174: 5789–5795
  • Brasier A R, Recinos A, III, Eledrisi M S. Vascular inflammation and the renin–angiotensin system. Arterioscler Thromb Vasc Biol 2002; 22: 1257–1266
  • Brun P, Castagliuolo I, Di LV, Buda A, Pinzani M, Palu' G, Martines D. Increased intestinal permeability in obese mice: new evidences in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2006; 292: G518–525
  • Chandran M, Phillips S A, Ciaraldi T, Henry R R. Adiponectin: more than just another fat cell hormone?. Diabetes Care 2003; 26: 2442–2450
  • Chavakis T, Bierhaus A, Al-Fakhri N, Schneider D, Witte S, Linn T, Nagashima M, Morser J, Arnold B, Preissner K T, Nawroth P P. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med 2003; 198: 1507–1515
  • Chen C C, Li T C, Li C I, Liu C S, Wang H J, Lin C C. Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters. Metabolism 2005; 54: 471–475
  • Chen N G, Holmes M, Reaven G M. Relationship between insulin resistance, soluble adhesion molecules, and mononuclear cell binding in healthy volunteers. J Clin Endocrinol Metab 1999; 84: 3485–3489
  • Chen T H, Chen L, Hsieh M S, Chang C P, Chou D T, Tsai S H. Evidence for a protective role for adiponectin in osteoarthritis. Biochim Biophys Acta 2006; 1762: 711–718
  • Cipolletta C, Ryan K E, Hanna E V, Trimble E R. Activation of peripheral blood CD14+ monocytes occurs in diabetes. Diabetes 2005; 54: 2779–2786
  • Considine R V, Sinha M K, Heiman M L, Kriauciunas A, Stephens T W, Nyce M R, Ohannesian J P, Marco C C, McKee L J, Bauer T L, Caro J F. Serum immunoreactive-leptin concentration in normal-weight and obese humans. N Engl J Med 1996; 334: 292–295
  • Corsonello A, Perticone F, Malara A, De D D, Loddo S, Buemi M, Ientile R, Corica F. Leptin-dependent platelet aggregation in healthy, overweight and obese subjects. Int J Obes Relat Metab Disord 2003; 27: 566–573
  • Couillard C, Ruel G, Archer W R, Pomerleau S, Bergeron J, Couture P, Lamarche B, Bergeron N. Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. J Clin Endocrinol Metab 2005; 90: 6454–6459
  • Dalrymple S A, Lucian L A, Slattery R, McNeil T, Aud D M, Fuchino S, Lee F, Murray R. Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect Immun 1995; 63: 2262–2268
  • Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 2004; 25: 4–7
  • Dandona P, Aljada A, Mohanty P. The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia 2002; 45: 924–930
  • de Boer O J, van der Wal A C, Becker A E. Atherosclerosis, inflammation, and infection. J Pathol 2000; 190: 237–243
  • Dencker M, Thorsson O, Karlsson M K, Linden C, Wollmer P, Ahren B. Leptin is closely related to body fat in prepubertal children aged 8–11 years. Acta Paediatr 2006; 95: 975–979
  • Devaraj S, Venugopal S K, Singh U, Jialal I. Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-alpha and -beta. Diabetes 2005; 54: 85–91
  • du Toit E F, Nabben M, Lochner A. A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury. Basic Res Cardiol 2005; 100: 346–354
  • El-Solh A A, Sikka P, Ramadan F. Outcome of older patients with severe pneumonia predicted by recursive partitioning. J Am Geriatr Soc 2001; 49: 1614–1621
  • Elbatarny H S, Maurice D H. Leptin-mediated activation of human platelets: involvement of a leptin receptor and phosphodiesterase 3A-containing cellular signaling complex. Am J Physiol Endocrinol Metab 2005; 289: E695–E702
  • Esposito K, Pontillo A, Di P C, Giugliano G, Masella M, Marfella R, Giugliano D. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003; 289: 1799–1804
  • Fain J N, Madan A K, Hiler M L, Cheema P, Bahouth S W. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004; 145: 2273–2282
  • Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005; 115: 911–919
  • Farooqi I S, Matarese G, Lord G M, Keogh J M, Lawrence E, Agwu C, Sanna V, Jebb S A, Perna F, Fontana S, Lechler R I, De Paoli A M, O'Rahilly S. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 2002; 110: 1093–1103
  • Farvid M S, Ng T W, Chan D C, Barrett P H, Watts G F. Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia. Diabetes Obes Metab 2005; 7: 406–413
  • Fogelstrand L, Hulthe J, Hulten L M, Wiklund O, Fagerberg B. Monocytic expression of CD14 and CD18, circulating adhesion molecules and inflammatory markers in women with diabetes mellitus and impaired glucose tolerance. Diabetologia 2004; 47: 1948–1952
  • Folsom A R, Qamhieh H T, Wing R R, Jeffery R W, Stinson V L, Kuller L H, Wu K K. Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults. Arterioscler Thromb 1993; 13: 162–169
  • Fried S K, Bunkin D A, Greenberg A S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998; 83: 847–850
  • Friedman J M, Halaas J L. Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763–770
  • Fu Y, Luo L, Luo N, Garvey W T. Proinflammatory cytokine production and insulin sensitivity regulated by overexpression of resistin in 3T3-L1 adipocytes. Nutr Metab (Lond) 2006; 3: 28–37
  • Ghanim H, Dhindsa S, Aljada A, Chaudhuri A, Viswanathan P, Dandona P. Low-dose rosiglitazone exerts an antiinflammatory effect with an increase in adiponectin independently of free fatty acid fall and insulin sensitization in obese type 2 diabetics. J Clin Endocrinol Metab 2006; 91: 3553–3558
  • Giandomenico G, Dellas C, Czekay R P, Koschnick S, Loskutoff D J. The leptin receptor system of human platelets. J Thromb Haemost 2005; 3: 1042–1049
  • Goichot B, Grunebaum L, Desprez D, Vinzio S, Meyer L, Schlienger J L, Lessard M, Simon C. Circulating procoagulant microparticles in obesity. Diabetes Metab 2006; 32: 82–85
  • Griendling K K, Ushio-Fukai M, Lassegue B, Alexander R W. Angiotensin II signaling in vascular smooth muscle. New Concepts Hypertension 1997; 29: 366–373
  • Hauner H. Secretory factors from human adipose tissue and their functional role. Proc Nutr Soc 2005; 64: 163–169
  • Hotamisligil G S, Arner P, Caro J F, Atkinson R L, Spiegelman B M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409–2415
  • Hotamisligil G S, Shargill N S, Spiegelman B M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87–91
  • Hsueh W A, Lyon C J, Quinones M J. Insulin resistance and the endothelium. Am J Med 2004; 117: 109–117
  • Juhan-Vague I, Morange P E, Alessi M C. The insulin resistance syndrome: implications for thrombosis and cardiovascular disease. Pathophysiol Haemost Thromb 2002; 32: 269–273
  • Kaser S, Kaser A, Sandhofer A, Ebenbichler C F, Tilg H, Patsch J R. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 2003; 309: 286–290
  • Katakam P V, Jordan J E, Snipes J A, Tulbert C D, Miller A W, Busija D W. Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker obese rats with insulin resistance. Am J Physiol Regul Integr Comp Physiol 2006, (E-pub ahead of print: PMID:17008456)
  • Kawanami D, Maemura K, Takeda N, Harada T, Nojiri T, Imai Y, Manabe I, Utsunomiya K, Nagai R. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Res Commun 2004; 314: 415–419
  • Kobashi C, Urakaze M, Kishida M, Kibayashi E, Kobayashi H, Kihara S, Funahashi T, Takata M, Temaru R, Sato A, Yamazaki K, Nakamura N, Kobayashi M. Adiponectin inhibits endothelial synthesis of interleukin-8. Circ Res 2005; 97: 1245–1252
  • Konstantinides S, Schafer K, Koschnick S, Loskutoff D J. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest 2001; 108: 1533–1540
  • Konstantinides S, Schafer K, Neels J G, Dellas C, Loskutoff D J. Inhibition of endogenous leptin protects mice from arterial and venous thrombosis. Arterioscler Thromb Vasc Biol 2004; 24: 2196–2201
  • Kougias P, Chai H, Lin P H, Lumsden A B, Yao Q, Chen C. Adipocyte-derived cytokine resistin causes endothelial dysfunction of porcine coronary arteries. J Vasc Surg 2005; 41: 691–698
  • Kumada M, Kihara S, Ouchi N, Kobayashi H, Okamoto Y, Ohashi K, Maeda K, Nagaretani H, Kishida K, Maeda N, Nagasawa A, Funahashi T, Matsuzawa Y. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 2004; 109: 2046–2049
  • Kurukulasuriya L R, Govindarajan G, Sowers J. Stroke prevention in diabetes and obesity. Expert Rev Cardiovasc Ther 2006; 4: 487–502
  • Laursen J B, Rajagopalan S, Galis Z, Tarpey M, Freeman B A, Harrison D G. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 1997; 95: 588–593
  • Lee G H, Proenca R, Montez J M, Carroll K M, Darvishzadeh J G, Lee J I, Friedman J M. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996; 379: 632–635
  • Lee Y H, Pratley R E. The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep 2005; 5: 70–75
  • Lollmann B, Gruninger S, Stricker-Krongrad A, Chiesi M. Detection and quantification of the leptin receptor splice variants Ob-Ra, b, and, e in different mouse tissues. Biochem Biophys Res Commun 1997; 238: 648–652
  • Lord G M, Matarese G, Howard J K, Baker R J, Bloom S R, Lechler R I. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998; 394: 897–901
  • Lord G M, Matarese G, Howard J K, Bloom S R, Lechler R I. Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. J Leukoc Biol 2002; 72: 330–338
  • Loskutoff D J, Samad F. The adipocyte and hemostatic balance in obesity: studies of PAI-1. Arterioscler Thromb Vasc Biol 1998; 18: 1–6
  • Lyon C J, Law R E, Hsueh W A. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 2003; 144: 2195–2200
  • Maruyama I, Nakata M, Yamaji K. Effect of leptin in platelet and endothelial cells. Obesity and arterial thrombosis. Ann N Y Acad Sci 2000; 902: 315–319
  • Masaki T, Chiba S, Tatsukawa H, Yasuda T, Noguchi H, Seike M, Yoshimatsu H. Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice. Hepatology 2004; 40: 177–184
  • Massiera F, Bloch-Faure M, Ceiler D, Murakami K, Fukamizu A, Gasc J M, Quignard-Boulange A, Negrel R, Ailhaud G, Seydoux J, Meneton P, Teboul M. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J 2001; 15: 2727–2729
  • Mateo T, bu Nabah Y N, Abu T M, Mata M, Cerda-Nicolas M, Proudfoot A E, Stahl R A, Issekutz A C, Cortijo J, Morcillo E J, Jose P J, Sanz M J. Angiotensin II-induced mononuclear leukocyte interactions with arteriolar and venular endothelium are mediated by the release of different CC chemokines. J Immunol 2006; 176: 5577–5586
  • Mokdad A H, Serdula M K, Dietz W H, Bowman B A, Marks J S, Koplan J P. The continuing epidemic of obesity in the United States. JAMA 2000; 284: 1650–1651
  • Montague C T, Rarooqi I S, Whitehead J P, Soos M A, Rau H, Wareham N J, Sewter C P, Digby J E, Mohammed S M, Hurst J A, Cheetham C H, Earley A R, Barnett A H, Prins J B, O'Rahilly S. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997; 387: 903–908
  • Muse E D, Obici S, Bhanot S, Monia B P, McKay R A, Rajala M W, Scherer P E, Rossetti L. Role of resistin in diet-induced hepatic insulin resistance. J Clin Invest 2004; 114: 232–239
  • Nishina P M, Naggert J K, Verstuyft J, Paigen B. Atherosclerosis in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow. Metabolism 1994; 43: 554–558
  • Otero M, Lago R, Lago F, Casanueva F F, Diequez C, Gomez-Reino J J, Gualillo O. Leptin, from fat to inflammation: old questions and new insights. FEBS Lett 2005; 579: 295–301
  • Otero M, Lago R, Gomez R, Dieguez C, Lago F, Gomez-Reino J, Gualillo O. Towards a pro-inflammatory and immunomodulatory emerging role of leptin. Rheumatology (Oxford) 2006; 45: 944–950
  • Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: 2473–2476
  • Ouvina S M, La Greca R D, Zanaro N L, Palmer L, Sassetti B. Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type II patients. Thromb Res 2001; 102: 107–114
  • Pacifico L, Di R L, Anania C, Osborn J F, Ippoliti F, Schiavo E, Chiesa C. Increased T-helper interferon-gamma-secreting cells in obese children. Eur J Endocrinol 2006; 154: 691–697
  • Pannacciulli N, Vettor R, Milan G, Granzotto M, Catucci A, Federspil G, De G P, Giorgino R, De P G. Anorexia nervosa is characterized by increased adiponectin plasma levels and reduced nonoxidative glucose metabolism. J Clin Endocrinol Metab 2003; 88: 1748–1752
  • Pasceri V, Willerson J T, Yeh E T. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102: 2165–2168
  • Pepys M B, Hirschfield G M. C-reactive protein: a critical update. J Clin Invest 2003; 111: 1805–1812
  • Petnehazy T, Stokes K Y, Russell J M, Granger D N. Angiotensin II type-1 receptor antagonism attenuates the inflammatory and thrombogenic responses to hypercholesterolemia in venules. Hypertension 2005; 45: 209–215
  • Piqueras L, Kubes P, Alvarez A, O'Connor E, Issekutz A C, Esplugues J V, Sanz M J. Angiotensin II induces leukocyte-endothelial cell interactions in vivo via AT(1) and AT(2) receptor-mediated P-selectin upregulation. Circulation 2000; 102: 2118–2123
  • Rahmouni K, Haynes W G. Endothelial effects of leptin: implications in health and diseases. Curr Diab Rep 2005; 5: 260–266
  • Rahmouni K, Mark A L, Haynes W G, Sigmund C D. Adipose depot-specific modulation of angiotensinogen gene expression in diet-induced obesity. Am J Physiol Endocrinol Metab 2004; 286: E891–E895
  • Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 2006; 64: 355–365
  • Schaffler A, Ehling A, Neumann E, Herfarth H, Tarner I, Scholmerich J, Muller-Ladner U, Gay S. Adipocytokines in synovial fluid. JAMA 2003; 290: 1709–1710
  • Shibata R, Sato K, Pimentel D R, Takemura Y, Kihara S, Ohashi K, Funahashi T, Ouchi N, Walsh K. Adiponectin protects against myocardial ischemia–reperfusion injury. Nat Med 2005; 11: 1096–1103
  • Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, Yamashita S, Miura M, Fukuda Y, Takemura K, Tokunaga K, Matsuzawa Y. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 1996; 2: 800–803
  • Silswal N, Singh A K, Aruna B, Mukhopadhyay S, Ghosh S, Ehtesham N Z. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun 2005; 334: 1092–1101
  • Smith C C, Mocanu M M, Davidson S M, Wynne A M, Simpkin J C, Yellon D M. Leptin, the obesity-associated hormone, exhibits direct cardioprotective effects. Br J Pharmacol 2006; 149: 5–13
  • Sprung C L, Peduzzi P N, Shatney C H, Schein R M, Wilson M F, Sheagren J N, Hinshaw L B. Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group. Crit Care Med 1990; 18: 801–806
  • Stein P D, Beemath A, Olson R E. Obesity as a risk factor in venous thromboembolism. Am J Med 2005; 118: 978–980
  • Steinberg H O, Chaker H, Leaming R, Johnson A, Brechtel G, Baron A D. Obesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance. J Clin Invest 1996; 97: 2601–2610
  • Steppan C M, Brown E J, Wright C M, Bhat S, Banerjee R R, Dai C Y, Enders G H, Silberg D G, Wen X, Wu G D, Lazar M A. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA 2001; 98: 502–506
  • Steppan C M, Lazar M A. The current biology of resistin. J Intern Med 2004; 255: 439–447
  • Suzuki M, Aoshiba K, Nagai A. Oxidative stress increases Fas ligand expression in endothelial cells. J Inflamm (Lond) 2006; 3: 11–15
  • Symmons D P. Looking back: rheumatoid arthritis—aetiology, occurrence and mortality. Rheumatology (Oxford) 2005; 44: iv14–iv17, Suppl 4
  • Tachoepe D, Rolson P, Schripper B. Platelets in diabetes: the role in the hemostatic regulation in atherosclerosis. Semin Thromb Haemostasis 2006; 19: 122–128
  • Tigno X T, Selaru I K, Angeloni S V, Hansen B C. Is microvascular flow rate related to ghrelin, leptin and adiponectin levels?. Clin Hemorheol Microcirc 2003; 29: 409–416
  • Unger R H, Zhou Y T, Orci L. Regulation of fatty acid homeostasis in cells: novel role of leptin. Proc Natl Acad Sci USA 1999; 96: 2327–2332
  • Vachharajani V, Russell J M, Scott K L, Conrad S, Stokes K Y, Tallam L, Hall J, Granger D N. Obesity exacerbates sepsis-induced inflammation and microvascular dysfunction in mouse brain. Microcirculation 2005; 12: 183–194
  • Vachharajani V, Vital S, Russell J, Scott L K, Granger D N. Glucocorticoids inhibit the cerebral microvascular dysfunction associated with sepsis in obese mice. Microcirculation 2006; 13: 477–487
  • van Baal P H, Hoogenveen R T, de Wit G A, Boshuizen H C. Estimating health-adjusted life expectancy conditional on risk factors: results for smoking and obesity. Popul Health Metr 2006; 4: 14–26
  • Verma S, Li S H, Wang C H, Fedak P W, Li R K, Weisel R D, Mickle D A. Resistin promotes endothelial cell activation: further evidence of adipokine–endothelial interaction. Circulation 2003; 108: 736–740
  • Viguerie N, Vidal H, Arner P, Holst C, Verdich C, Avizou S, Astrup A, Saris W H, Macdonald I A, Klimcakova E, Clement K, Martinez A, Hoffstedt J, Sorensen T I, Langin D. Adipose tissue gene expression in obese subjects during low-fat and high-fat hypocaloric diets. Diabetologia 2005; 48: 123–131
  • Visser M, Bouter L M, McQuillan G M, Wener M H, Harris T B. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282: 2131–2135
  • Wassmann S, Stumpf M, Strehlow K, Schmid A, Schieffer B, Bohm M, Nickenig G. Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circ Res 2004; 94: 534–541
  • Wautier J L, Schmidt A M. Protein glycation: a firm link to endothelial cell dysfunction. Circ Res 2004; 95: 233–238
  • Weisberg S P, McCann D, Desai M, Rosenbaum M, Leibel R L, Ferrante A W, Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796–1808
  • Westerbacka J, Vehkavaara S, Bergholm R, Wilkinson I, Cockcroft J, Yki-Jarvinen H. Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity. Diabetes 1999; 48: 821–827
  • Westerbacka J, Yki-Jarvinen H, Turpeinen A, Rissanen A, Vehkavaara S, Syrjala M, Lassila R. Inhibition of platelet-collagen interaction: an in vivo action of insulin abolished by insulin resistance in obesity. Arterioscler Thromb Vasc Biol 2002; 22: 167–172
  • Wolf A M, Wolf D, Rumpold H, Enrich B, Tilg H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 2004; 323: 630–635
  • Wolk R, Deb A, Caplice N M, Somers V K. Leptin receptor and functional effects of leptin in human endothelial progenitor cells. Atherosclerosis 2005; 183: 131–139
  • Wu-Peng X S, Chua S C, Jr., Okada N, Liu S M, Niclson M, Leibel R L. Phenotype of the obese Koletsky (f) rat due to Tyr763Stop mutation in the extracellular domain of the leptin receptor (Lepr): evidence for deficient plasma-to-CSF transport of leptin in both the Zucker and Koletsky obese rat. Diabetes 1997; 46: 513–518
  • Wulster-Radcliffe M C, Ajuwon K M, Wang J, Christian J A, Spurlock M E. Adiponectin differentially regulates cytokines in porcine macrophages. Biochem Biophys Res Commun 2004; 316: 924–929
  • Yaegashi M, Jean R, Zuriqat M, Noack S, Homel P. Outcome of morbid obesity in the intensive care unit. J Intensive Care Med 2005; 20: 147–154
  • Yamagishi S I, Edelstein D, Du X L, Kaneda Y, Guzman M, Brownlee M. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 2001; 276: 25096–25100
  • Zarkesh-Esfahani H, Pockley A G, Wu Z, Hellewell P G, Weetman A P, Ross R J. Leptin indirectly activates human neutrophils via induction of TNF-alpha. J Immunol 2004; 172: 1809–1814
  • Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425–432
  • Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, D'Andrea F, Molinari A M, Giugliano D. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002; 105: 804–809
  • Zwerina J, Redlich K, Schett G, Smolen J S. Pathogenesis of rheumatoid arthritis: targeting cytokines. Ann N Y Acad Sci 2005; 1051: 716–729

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.